Skip to content
NASDAQ · AGRICULTURAL CHEMICALS · SMALL CAP

Cibus, Inc. CBUS

11 fiscal years on record · USD · FY2025 reported · SEC filings only
$3.6M
▼ 14.6% YoY
$-127.1M
$-51.2M

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

In brief

What this company does

Cibus is a leading agricultural biotechnology company that primarily uses proprietary gene editing technologies to develop plant traits, which are specific genetic characteristics in the DNA of a plant’s seed. Over the course of its history, Cibus has developed a proprietary time bound and predictable gene editing platform referred to as the Rapid Trait Development System™ (RTDS®). Cibus’ primary business is focused on the development of plant traits for some of the world’s major agricultural crops that help address specific productivity, profitability, sustainability, or yield challenges in farming. In the near term, Cibus’ priority pipeline program centers on Rice herbicide tolerance (HT) traits. Alongside its Rice program, Cibus also continues to advance its sustainable ingredients program, including lauric oils and bio fragrance products, the development of which is currently partially partner-funded and/or supported by a consumer-packaged goods partner. On July 21, 2025, the Board of Directors of Cibus (Board) approved a reduction in workforce of approximately 34 full-time employees as a pivotal step in implementing the Company’s streamlined business focus.

Written from the business description in Cibus, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 17 March 2026. Every sentence was checked against that document before publication.

Growth

USD 3.6M
Revenue, FY2025 · full 11-year series below
Revenue $M Net income $M
FY2025 · Revenue 3.6 · Net income -127.1
-100M-200M
20152018202120242025
Compound annual growth
+185.1%
−31.3%
+11.1%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at −31.3% a year over the five years to FY2025.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

·
Operating margin Net margin
FY2025 · Operating -2680.1% · Net ·
-5000%-10000%-15000%
201520202025
ROE
FY2025 · ROE -223.0%
-100%-200%
201520202025
Three returns, three denominators.

Each USD of equity lost 223 cents this year.

Cash & shareholders

·
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF -51.2
-25.0M-50.0M
201520202025
Net buybacks $M Dividends $M
FY2019 · Dividends · · Net buybacks 0.8
-25.0M-50.0M
201520182019

Total assetsUSD 305.0M
EquityUSD 21.8M
CashUSD 9.9M
Gross debtUSD 528,000.00
Net debtUSD -9.4M
Current ratio0.72×

The company holds more cash than debt.

The 11-year record

11 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative—not applicable◌not available in our data
CBUS, 11-year financial record
Metric 20252024202320222021202020192018201720162015
Revenue $B0.00.00.00.00.00.00.00.00.00.00.0
Operating income $B−0.1−0.3−0.3−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
EBITDA $B−0.1−0.3−0.3−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
Income tax $B0.00.0−0.00.00.00.00.00.00.00.00.0
Net income $B−0.1−0.3−0.3−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
Free cash flow $B−0.1−0.1−0.1−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
EPS, diluted $−2.78−10.83−25.95−18.36−0.78−1.32−1.21−0.91−1.12−0.62−0.88
Dividend / sh $◌◌◌◌◌◌◌◌◌◌◌
Payout %——————————−2
ROE %−223.0−130.4−178.0−158.1−114.5−90.2−50.8−37.0−73.6−64.7−24.3
Shares out B◌0.030.020.050.040.040.030.030.030.02◌

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

Provenance

Company facts, as filed

How we verify · 0 failures in 46 reconciliationsAUDITED

Reconciled in 11 of the 11 fiscal years we could check. 18 checks were skipped: the balance sheet is not tagged before 2016. Eight checks were skipped: EPS is not tagged before 2015. Eight checks were skipped: revenue is not tagged before 2015.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency0 failures
ActivityAgricultural Chemicals
Listed onNASDAQ
Incorporated inDelaware
Fiscal year endsDecember 31
SEC categorysmaller reporting company
Data on record since2015

Share this section

Download image